CIK 0001612940 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in P7 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-23 | 6-K | FORM 6-K | 2026-09-23 |
| 2026-09-09 | 6-K | FORM 6-K | 2026-09-09 |
| 2026-08-13 | 6-K | 6-K | 2026-06-30 |
| 2026-08-13 | 6-K | FORM 6-K | 2026-08-13 |
| 2026-08-03 | 4 | OWNERSHIP DOCUMENT | 2026-07-31 |
| 2026-07-29 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-07-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-24 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-21 | 4 | OWNERSHIP DOCUMENT | 2026-07-17 |
| 2026-07-15 | EFFECT | EFFECT items ,, | |
| 2026-07-15 | 424B5 | 424B5 | |
| 2026-07-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-13 | 4 | OWNERSHIP DOCUMENT | 2026-07-09 |
| 2026-07-08 | 4 | OWNERSHIP DOCUMENT | 2026-07-07 |
| 2026-07-06 | F-3 | F-3 | |
| 2026-06-30 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-30 | 4/A | OWNERSHIP DOCUMENT | 2026-06-02 |
| 2026-06-30 | 4 | OWNERSHIP DOCUMENT | 2026-06-26 |
| 2026-06-26 | 6-K | FORM 6-K | 2026-06-26 |
| 2026-06-26 | 424B5 | 424B5 | |
| 2026-06-25 | 6-K | FORM 6-K | 2026-06-25 |
| 2026-06-03 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-03 | 4 | OWNERSHIP DOCUMENT | 2026-06-02 |
| 2026-06-02 | 6-K | FORM 6-K | 2026-06-02 |
| 2026-06-02 | 3 | OWNERSHIP DOCUMENT | 2026-06-02 |
Forms on file (last 1,000): 6-K 184, SC 13G/A 49, 424B5 23, SC 13G 20, CORRESP 13, 20-F 12, UPLOAD 12, 3 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PRQR (0.002 USD), /gw/filings/filings?ticker=PRQR&form=8-K, /gw/filings/facts?ticker=PRQR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange